Government & Policy

Healthcare IT News is maintaining a list of trusted information sources with key details to help stem the ongoing spread of COVID-19.

While Epic says it is reviewing the info-blocking and patient-access rules to see how they impact four specific areas, Cerner has voiced its "ardent support" to HHS.

The changes are expected to be significant. At the moment, although 80% of adults support donation, only 38% have opted in to it.

As the Kingdom suspends travel to nine more countries, it is hoped that its donation – as well as others from around the world – will fast track the development of a drug for novel coronavirus.

Europe’s GDPR has been considered a trailblazer. But it turns out that interpreting it is difficult, and digital healthcare is where these difficulties manifest most.

A new update implemented by the Australian federal government will allow doctors, nurses and mental health practitioners to provide telehealth services, such as video conferencing, to people isolated at home due to the coronavirus. 

Industry groups including AHIP, MGMA and the AMA support the patient access aims of the final regs, but have qualms about third-party developers and the compliance burden for providers.

Facebook, Google and Twitter take action to ensure accurate health advice on their platforms.

On March 9, the Innovation and Technology Commission (ITC) in Hong Kong launched a special call under the Public Sector Trial Scheme for projects to support product development and application of technologies for the prevention and control of COVID-19.  WHAT’S IT ABOUT The special round aims to fund trials of R&D outcomes in the local public sector relating to detection, diagnosis or surveillance of the COVID-19 virus, or reduction of the risks of infection and its spread. According to its official release, the R&D outcomes should be immediately ready for trials by government departments or the relevant public organizations to bring about benefits for the community in fighting the epidemic in the near future. The target funding recipients are local R&D centers, universities and other designated public research institutes, as well as all technology companies conducting R&D activities in Hong Kong. The funding ceiling for each project is HKD $2M in general, and a higher ceiling for individual projects may be considered if necessary and justified. Applications will be accepted from now until April 10, and more details are available here.  THE LARGER TREND Last week, Singapore-born, Boston-based digital therapeutics startup Biofourmis announced that its technology is being utilized in a remote monitoring and disease surveillance program in Hong Kong involving patients with diagnosed or suspect cases of COVID-19. The program is being administered by the University of Hong Kong.  Elsewhere in APAC, governments or public agencies are collaborating with healthtech startups to tackle the management and/or diagnosis of COVID-19. Singapore’s national HIT agency, IHiS, has worked with local healthcare AI startup Kronikare to pilot iThermo – an AI-powered temperature screening solution that screens and identifies those having or showing symptoms of fever, HealthcareITNews reported. Singapore-based Veredus Laboratories worked with the Home Team Science and Technology Agency (HTX), a statutory board under the Ministry of Home Affairs, to develop its VereCoV Detection Kit, a portable Lab-on-Chip application capable of detecting the 2019 Novel Coronavirus (COVID-19) in a single test, according to MobiHealthNews report. ON THE RECORD “The aim of the call is not only to promote the realization and commercialization of local R&D outcomes, but also to encourage the public sector to use technologies for tackling the COVID-19 epidemic in Hong Kong, thereby bearing dual significance,” said an ITC spokesman in a statement. 

National Coordinator Don Rucker and Deputy National Coordinator Steve Posnack talk enforcement timelines, "content and manner," FHIR 4, gag clause provisions, patient privacy and more.